Compare Neurocrine Biosciences Inc (NBIX) vs Opendoor Technologies Inc (OPEN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Neurocrine Biosciences Inc vs Opendoor Technologies Inc — how do they compare? Neurocrine Biosciences Inc trades at $179.88 (market cap $17.40B), while Opendoor Technologies Inc trades at $4.48 (market cap $4.29B). The key difference: Neurocrine Biosciences Inc is far larger — about 4.1× Opendoor Technologies Inc's market cap, and Neurocrine Biosciences Inc is trading nearer its 52-week high, Opendoor Technologies Inc nearer its low. Which is the better fit depends on your goals.
| NBIX | OPEN | |
|---|---|---|
Market Cap | $17.40B | $4.29B |
Sector | Health | Real Estate |
52-Week High | $180.55 | $10.52 |
52-Week Low | $123.10 | $1.84 |
Enterprise Value | $16.49B | $4.63B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Neurocrine Biosciences Inc
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →About Opendoor Technologies Inc
Opendoor Technologies Inc is a digital platform for residential real estate. This platform enables customers to buy and sell houses online. It generates revenue through home sales, along with other revenue from real estate services.
Read more on OPEN →
